Annexin II: a plasminogen-plasminogen activator co-receptor

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

1997 • 3,167 citations

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

1998 • 985 citations

Dysregulation of Apoptosis in Cancer

1999 • 983 citations

Superficial Bladder Cancer: Progression and Recurrence

1983 • 947 citations

Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.

1998 • 720 citations

An Anti-apoptotic Protein Human Survivin Is a Direct Inhibitor of Caspase-3 and -7

2001 • 670 citations

Two molecular pathways to transitional cell carcinoma of the bladder.

1994 • 599 citations

Expression of survivin and its relationship to loss of apoptosis in breast carcinomas

2000 • 561 citations

A Novel Anti-Apoptosis Gene: Re-expression of Survivin Messenger RNA as a Prognosis Marker in Non–Small-Cell Lung Cancers

1999 • 498 citations

A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy.

2000 • 491 citations

Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas.

1998 • 473 citations

High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma

2000 • 392 citations

Prognostic significance of survivin expression in diffuse large B-cell lymphomas

2000 • 368 citations

PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATURE

1998 • 285 citations

Urine Detection of Survivin and Diagnosis of Bladder Cancer

2001 • 280 citations

URINARY HYALURONIC ACID AND HYALURONIDASE: MARKERS FOR BLADDER CANCER DETECTION AND EVALUATION OF GRADE

2000 • 221 citations

NATURAL HISTORY OF SUPERFICIAL BLADDER CANCER

1992 • 214 citations

URINE CYTOLOGY

2000 • 205 citations

Epidemiology and Etiology of Premalignant and Malignant Urothelial Changes

2000 • 195 citations

CAN URINE BOUND DIAGNOSTIC TESTS REPLACE CYSTOSCOPY IN THE MANAGEMENT OF BLADDER CANCER?

1998 • 177 citations

A Community Study of Bladder Cancer Screening by the Detection of Occult Urinary Bleeding

1992 • 165 citations

Home Screening for Hematuria: Results of a Multi-Clinic Study

1992 • 159 citations

Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer.

1993 • 158 citations

Expression of survivin and Bcl-2 in the normal human endometrium

2000 • 156 citations

Strategies for Asymptomatic Microscopic Hematuria: A Prospective Study of 1,034 Patients

1990 • 147 citations

Clinical evaluation of the BTA trak assay and comparison to voided urine cytology and the bard BTA test in patients with recurrent bladder tumors

1997 • 139 citations

Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer.

1999 • 110 citations

Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.

1998 • 65 citations

NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer.

1999 • 47 citations

The survivin: Fas ratio in pediatric renal tumors

2001 • 42 citations

Monitoring patients for bladder neoplasms: what can be expected of urinary cytology consultations in clinical practice

1999 • 38 citations

Expression of survivin in esophageal cancer: Correlation with the prognosis and response to chemotherapy

2001 • 33 citations

COMPARISON OF SCREENING METHODS IN THE DETECTION OF BLADDER CANCER

1999 • 28 citations

Bladder cancer screening.

1996 • 28 citations

Diagnostic Value of Voided Urine and Bladder Barbotage Cytology in Detecting Transitional Cell Carcinoma of the Urinary Tract

1999 • 25 citations

CURRENT BLADDER TUMOR TESTS: DOES THEIR PROJECTED UTILITY FULFILL CLINICAL NECESSITY?

2001 • 20 citations

[Usefulness of BTA Stat test (Bard) in the diagnosis of bladder cancer. Preliminary results and comparison with cytology and cystoscopy].

1998 • 14 citations

Sensitivity and Specificity of NMP-22, Telomerase, and BTA in the Detection of Human Bladder Cancer

1999 • 14 citations

Neuroendocrine cells in human prostate over‐express the anti‐apoptosis protein survivin

2001 • 10 citations

SENSITIVITY ANALYSIS OF THE DIAGNOSTIC VALUE OF ENDOSCOPIES IN CROSS-SECTIONAL STUDIES IN THE ABSENCE OF A GOLD STANDARD

2000 • 8 citations

Urinary NMP22 for the Detection of Recurrence After Transurethral Resection of Transitional Cell Carcinoma of the Bladder: Experience on 137 Patients

1999 • 7 citations

Deleted Work

1955 • 0 citations